Only one study comparing insulin users versus non-insulin-users showed a statistically significant decreased risk of breast cancer (HR 0.86; 95 % CI 0.81, 0.91) in patients with type 2 diabetes [60]. Here, INS is linked to type 2 diabetes mellitus.